143 results on '"Vulchanova, Lucy"'
Search Results
2. Renal Nerves: Roles in Homeostasis and Pathophysiology
3. Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine
4. IL-1R–Mediated Activation of Renal Sensory Nerves in DOCA-Salt Hypertension
5. The nAChR Chaperone TMEM35a (NACHO) Contributes to the Development of Hyperalgesia in Mice
6. Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
7. Elucidating the Mechanism of the Spinal Effects by VGF-derived Peptide TLQP-62
8. Analysis of Brain Regions Activated by Afferent Renal Nerves in DOCA-Salt Hypertensive Mice
9. Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance
10. The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
11. AAV-mediated gene transfer to colon-innervating primary afferent neurons
12. Detailed Method for Intrathecal Delivery of Gene Therapeutics by Direct Lumbar Puncture in Mice
13. AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection
14. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection
15. Agmatine inhibits NMDA Receptor-mediated Calcium Transients in Spinal Cord Dorsal Horn
16. Editorial: The brain barriers in diseases of the nervous system
17. Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity
18. Periglomerular afferent innervation of the mouse renal cortex
19. Involvement of the VGF-derived peptide TLQP-62 in nerve injury–induced hypersensitivity and spinal neuroplasticity
20. Abstract 075: The Kidney-OVLT Neuroaxis Mediates Neurogenic Hypertension And Polydipsia In 2-Kidney, 1-Clip Rats
21. Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice
22. Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling
23. Renal Afferent Nerves Regulate Salt Appetite in DOCA Hypertensive Rats
24. TRPV1+ Sensory Fibers in the Mouse Renal Cortex ‐ Juxtaglomerular Anatomy and Optogenetic Stimulation
25. Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
26. Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection
27. Agmatine inhibits NMDA receptor–mediated calcium transients in mouse spinal cord dorsal horn via intact PSD95-nNOS signaling
28. Targeting the nociceptive somatosensory system with AAV9 and AAV2retro viral vectors
29. Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
30. Function of Renal Nerves in Kidney Physiology and Pathophysiology
31. Peripheral Deltorphin II Inhibits Nociceptors Following Nerve Injury
32. SPARC ‐ Anatomical Analysis and Optogenetic Stimulation of TRPV1+ Sensory Fibers in the Renal Cortex
33. Optogenetic‐induced sympathetic neuromodulation of brown adipose tissue thermogenesis
34. Elucidating the Mechanism of the Spinal Effects by VGF-derived Peptide TLQP-62
35. VGF and its C-terminal peptide TLQP-62 regulate memory formation and depressive behavior via a BDNF-TrkB-dependent mechanism
36. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
37. Optogenetic‐induced sympathetic neuromodulation of brown adipose tissue thermogenesis.
38. Neurologic improvement in a mouse model of Hunter syndrome (mucopolysaccharidosis type II) by treatment with AAV9 vector after the development of cognitive dysfunction
39. Relative effectiveness of different routes of AAV administration for gene therapy of mucopolysaccharidosis
40. 25. Intranasal Gene Delivery of AAV Iduronidase: An Effective and Non-Invasive Approach for Treatmentof CNS Disease in a Murine Model of MPS Type I
41. 369. Therapeutic Effectiveness of AAV-Mediated Iduronidase Delivery to the CNS Following Intravenous Administration in a Murine Model of Mucopolysaccharidosis Type I
42. 86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II
43. Agmatine inhibits NMDA Receptor-mediated Calcium Transients in Spinal Cord Dorsal Horn
44. The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells.
45. AAV9 mediated correction of iduronate-2-sulfatase deficiency in the central nervous system of mucopolysaccharidosis type II mice
46. Intranasal gene delivery of AAV9 iduronidase: A non-invasive and effective gene therapy approach for prevention of neurologic disease in a murine model of mucopolysaccharidosis type I
47. Gene delivery and biodistribution following intravenous administration of AAV9/rh10 iduronidase in a murine model of MPS type I
48. Current Gene Therapy using Viral Vectors for Chronic Pain
49. 369. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System of Mucopolysaccharidosis Type II Mice
50. 706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.